A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 ad...


GlaxoSmithKline, Inc

Principal Investigator

Dr. John Thorp, Obstetrics and Gynecology

Project Run Dates

8/10/2007 to 8/9/2010



The purpose of this study is to determine whether GSK232802 is safe and effective in reducing the frequency and severity of hot flashes associated with menopause.


Associated Publications and other materials

Study Record Detail on Clinical Trials.gov